NasdaqGS - Nasdaq Real Time Price USD
Kura Oncology, Inc. (KURA)
At close: November 5 at 4:00 PM EST
After hours: November 5 at 5:19 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
200,091.00
165,804.00
139,865.00
131,258.00
91,899.00
Operating Income
-200,091.00
-165,804.00
-139,865.00
-131,258.00
-91,899.00
Net Non Operating Interest Income Expense
18,341.00
13,173.00
4,025.00
792.00
2,274.00
Other Income Expense
--
--
--
--
51.00
Pretax Income
-181,750.00
-152,631.00
-135,840.00
-130,466.00
-89,625.00
Net Income Common Stockholders
-181,750.00
-152,631.00
-135,840.00
-130,466.00
-89,625.00
Diluted NI Available to Com Stockholders
-181,750.00
-152,631.00
-135,840.00
-130,466.00
-89,625.00
Basic EPS
-2.23
-2.08
-2.03
-1.97
-1.69
Diluted EPS
-2.23
-2.08
-2.03
-1.97
-1.69
Basic Average Shares
81,312.50
73,229.00
66,990.00
66,352.00
53,077.00
Diluted Average Shares
81,312.50
73,229.00
66,990.00
66,352.00
53,077.00
Total Expenses
200,091.00
165,804.00
139,865.00
131,258.00
91,899.00
Net Income from Continuing & Discontinued Operation
-181,750.00
-152,631.00
-135,840.00
-130,466.00
-89,625.00
Normalized Income
-181,750.00
-152,631.00
-135,840.00
-130,466.00
-89,625.00
Interest Income
19,943.00
14,722.00
4,254.00
1,206.00
2,852.00
Interest Expense
1,602.00
1,549.00
229.00
414.00
578.00
Net Interest Income
18,341.00
13,173.00
4,025.00
792.00
2,274.00
EBIT
-180,148.00
-151,082.00
-135,611.00
-130,052.00
-89,047.00
EBITDA
-179,282.00
-150,233.00
-134,852.00
-129,494.00
-88,853.00
Reconciled Depreciation
866.00
849.00
759.00
558.00
194.00
Net Income from Continuing Operation Net Minority Interest
-181,750.00
-152,631.00
-135,840.00
-130,466.00
-89,625.00
Normalized EBITDA
-179,282.00
-150,233.00
-134,852.00
-129,494.00
-88,853.00
12/31/2020 - 9/16/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SNDX Syndax Pharmaceuticals, Inc.
19.69
+3.96%
IDYA IDEAYA Biosciences, Inc.
29.58
-1.40%
BCYC Bicycle Therapeutics plc
23.51
+0.21%
SWTX SpringWorks Therapeutics, Inc.
31.59
+2.10%
MRUS Merus N.V.
51.75
+1.02%
KYMR Kymera Therapeutics, Inc.
47.69
+1.32%
KRYS Krystal Biotech, Inc.
174.41
+2.08%
REPL Replimune Group, Inc.
12.02
0.00%
PLRX Pliant Therapeutics, Inc.
14.90
+2.83%
RYTM Rhythm Pharmaceuticals, Inc.
56.25
+6.15%